Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters

An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections

(2019) Ha V. Dang et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

(2018) Norbert Pardi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

mRNA vaccines — a new era in vaccinology

(2018) Norbert Pardi et al.   NATURE REVIEWS DRUG DISCOVERY

Nipah Virus Outbreaks: Still Small but Extremely Lethal

(2018) Christina F Spiropoulou   JOURNAL OF INFECTIOUS DISEASES

Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease

(2017) Michelle Meyer et al.   JOURNAL OF INFECTIOUS DISEASES

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

(2017) Norbert Pardi et al.   NATURE

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

(2015) Norbert Pardi et al.   JOURNAL OF CONTROLLED RELEASE

Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease

(2015) Joseph Prescott et al.   VACCINE

Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters

(2013) Michael K. Lo et al.   ANTIVIRAL RESEARCH

Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months

(2013) Jackie A Pallister et al.   Virology Journal

Nipah Virus Infects Specific Subsets of Porcine Peripheral Blood Mononuclear Cells

(2012) Beata Stachowiak et al.   PLoS One

A Hendra Virus G Glycoprotein Subunit Vaccine Protects African Green Monkeys from Nipah Virus Challenge

(2012) K. N. Bossart et al.   Science Translational Medicine